Rockwell Medical (RMTI) EVP awarded 97,500 performance-based RSUs tied to stock
Rhea-AI Filing Summary
TIMMINS MEGAN C. reported acquisition or exercise transactions in this Form 4 filing.
ROCKWELL MEDICAL, INC. executive Megan C. Timmins, EVP, CLO and Secretary, received a grant of 97,500 performance-based restricted stock units (PSUs) tied to the company’s common stock. This is a compensation-related award, not an open-market stock purchase or sale.
The PSUs run for three years from the grant date and any unvested units are cancelled after the third anniversary. They can vest on or after the first anniversary only if a share-price performance hurdle is met over a 60-day trading window, using a base price of $2.14.
Positive
- None.
Negative
- None.
Insights
Routine performance-based equity grant with challenging vesting conditions.
Megan C. Timmins received 97,500 performance-based RSUs as part of equity compensation. The award is structured over a three-year term, ending on the third anniversary of the grant date, with cancellation of any unvested units at that time.
Vesting depends on the stock meeting a performance hurdle: the average closing price over any 60 consecutive trading days during the three-year performance period must reach two times the $2.14 base price. This creates a strong pay-for-performance link, as units vest only if the share price sustains a significantly higher level.
This filing shows no open-market buying or selling, only a grant/award acquisition. The transaction leaves Timmins holding 97,500 PSUs tied to common stock, with future vesting outcomes entirely dependent on share-price performance during the specified period.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance-based restricted stock units | 97,500 | $0.00 | $0.00 |
Footnotes (1)
- F1. These are performance-based restricted stock units ("PSU") with terms as follows. The term of each PSU award runs from the grant date through the third anniversary of the grant date. Any unvested PSUs remaining after the third anniversary will be cancelled. The performance period for the award is the same three-year period. PSUs will vest on or after the first anniversary of the grant date only if the stock price meets the performance hurdle. The performance hurdle is met if the average closing price of the Company's common stock over any 60 consecutive trading days during the performance period equals two times the base price. The base price was calculated as the average closing price over the ten trading days ending on the trading day prior to the grant date and is $2.14 for this award.
Key Figures
Key Terms
Performance-based restricted stock units financial
PSU financial
performance period financial
performance hurdle financial
average closing price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.